Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q1 2023 Earnings Call Transcript May 11, 2023
Capricor Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.31, expectations were $-0.32.
Operator: Good afternoon, ladies and gentlemen, this is the conference operator. Welcome to Capricor First Quarter 2023 Financial Results and Corporate Update Call. After the presentation there will be an opportunity to ask questions. [Operator Instructions] As a reminder, this conference is being...
